@article{5ff1f495c8ad4aacb8b67ef40a6c1589,
title = "Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 1: Developing and delivering high-quality independent clinical trials",
author = "{the UK Dermatology Clinical Trials Network} and Williams, {Hywel C.} and McPhee, {Margaret J.} and Layfield, {Carron P.} and Stephen Jones and Carron Layfield and Rubeta Matin and Nick Levell and Fiona Cowdell and Tim Burton and Adams, {Louisa May} and Jez Frankel and Kim Thomas and Gayathri Perera and Mary Sommerlad and Carolyn Charman and Sarah Worboys and Helen Young and Sharon Belmo and Tracey Sach and Lucy Bradshaw and Rachel Abbott and Abby Macbeth and Debbie Shipley and Areti Makrygeorgou and Tess McPherson and Claudia DeGiovanni and Evelyn Davies and Rhiannon Llewellyn and Melanie Westmoreland and Anjali Pathak and Hannah Wainman and Christina MacNeil and Richard Barlow and {de Brito}, Marianne and John Frewen and Anna Lalonde and Simi Sudhakaran and Eleanor Earp and Lloyd Steele and Andy Hodder and Alison Lowe and Alison Layton and Antonia Lloyd-Lavery and Shernaz Walton and Alison Sears and Esther Burden-Teh and Alana Durack and Aaron Wernham and Jason Thomson and Nadine Marrouche",
note = "Funding Information: The UK DCTN thanks the BAD for its sustained support over the last 20 years and all of the UK DCTN individual members including patients and those who serve on its committees (see Appendix) who give their time freely to support the network. The UK DCTN is a registered UK charity (number 1115745) and is subject to Charity Commission rules. The network infrastructure is funded by the BAD and the University of Nottingham, with contribution in kind and donations from its members. The network also receives some funding for continuing support and dissemination from successful applications. The network does not accept funding from the pharmaceutical industry or other for-profit organizations. Learning points The UK DCTN is a democratic network that strives to support high-quality clinical trials in dermatology. Patients are and always have been at the heart of the network. Clinical trial suggestions come from the network membership. Trial prioritization follows a process starting with an outline vignette that is heard by a steering group. The network directly supports the development of prioritized trial suggestions by means of surveys, expert critique and by directly funding feasibility studies. The output of UK DCTN has shown what is possible by working collaboratively across professional boundaries. The UK DCTN is a democratic network that strives to support high-quality clinical trials in dermatology. Patients are and always have been at the heart of the network. Clinical trial suggestions come from the network membership. Trial prioritization follows a process starting with an outline vignette that is heard by a steering group. The network directly supports the development of prioritized trial suggestions by means of surveys, expert critique and by directly funding feasibility studies. The output of UK DCTN has shown what is possible by working collaboratively across professional boundaries. Publisher Copyright: {\textcopyright} 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.",
year = "2022",
month = jun,
doi = "10.1111/ced.15140",
language = "English",
volume = "47",
pages = "1048--1059",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Oxford University Press",
number = "6",
}